Skip to main content

Table 1 Patients’ characteristics

From: Effect of topical bromfenac on intraretinal cystoid lesion in simultaneous cataract and idiopathic epiretinal membrane surgery

 

Group A

Group B

P

Age, mean (SD), years

66.3 (7.0)

66.7 (7.3)

0.790a

Sex (female: male)

18: 11

58: 31

0.763b

BCVA, median (IQR), LogMAR

   

 Baseline

0.40 (0.30, 0.50)

0.40 (0.30, 0.50)

0.534b

 3 months

6 months

0.20

(0.10, 0.30)

0.20

(0.00, 0.30)

0.20

(0.10, 0.40)

0.10

(0.10, 0.30)

0.731b

0.985b

 P

< 0.001c

< 0.001c

< 0.001c

< 0.001c

 

CMT, mean (SD), µm

   

 Baseline

439.3 (70.0)

432.2 (87.0)

0.657a

 3 months

6 months

376.6 (38.2)

370.7 (34.2)

360.0 (58.4)

344.4

(57.3)

0.156a

< 0.05a

 P

< 0.001d

< 0.001d

< 0.001d

< 0.001d

 

IRC, n, positive: negative

   

 Baseline

15: 14

36: 53

0.289b

 3 months

6 months

14: 15

12: 17

41: 48

29: 60

0.755b

0.395b

 P

1.000e

0.508e

0.383 e

0.281e

 

EIFL, n, positive: negative

   

 Baseline

22: 7

50: 39

0.060b

 3 months

6 months

15: 14

13: 16

32: 57

32: 57

0.134b

0.395b

 P

< 0.05 e

< 0.01e

< 0.001e

< 0.001e

 

ML, n, positive: negative -

18: 11

45: 44

0.283b

  1. BCVA best-corrected visual acuity, CMT central macular thickness, EIFL ectopic inner foveal layer, IRC intraretinal cystic lesions, IQR interquartile range, ML microvascular leakage
  2. at-test, bMann–Whitney U test, cWilcoxon signed-rank test, dpaired t-test, eMcNemar test